Clinical and histopathological features of patients with systemic sclerosis undergoing endomyocardial biopsy

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Mueller, Karin A L ^a   Mueller, Iris I ^a   Eppler, David ^a   Zuern, Christine S ^a   Seizer, Peter ^a   Kramer, Ulrich ^a   Koetter, Ina ^a   Roecken, Martin ^a   Kandolf, Reinhard ^a   Gawaz, Meinrad ^a   Geisler, Tobias ^a   Henes, Joerg C ^a   Klingel, Karin ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; AZATHIOPRINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BOSENTAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; METHOTREXATE; MYCOPHENOLIC ACID; PREDNISOLONE; RITUXIMAB; SILDENAFIL;

ADULT; ARTICLE; CARDIOVASCULAR MORTALITY; CARDITIS; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; FINGER ULCER; HEART ARRHYTHMIA; HEART CATHETERIZATION; HEART DISEASE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE BIOPSY; HEART MUSCLE FIBROSIS; HISTOPATHOLOGY; HOLTER MONITORING; HOSPITAL READMISSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INFLAMMATORY CELL; LABORATORY TEST; MALE; OUTCOME ASSESSMENT; PHENOTYPE; PULMONARY HYPERTENSION; SYSTEMIC SCLEROSIS; TRANSTHORACIC ECHOCARDIOGRAPHY; BIOPSY; CARDIAC MUSCLE; DEATH; ECHOCARDIOGRAPHY; FIBROSIS; HEART; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE; INFLAMMATION; MIDDLE AGED; MORTALITY; PATHOLOGY; PATHOPHYSIOLOGY;

ADULT; BIOPSY; DEATH; DEFIBRILLATORS, IMPLANTABLE; ECHOCARDIOGRAPHY; FEMALE; FIBROSIS; HEART; HEART FAILURE; HEART VENTRICLES; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; MYOCARDIUM; SCLERODERMA, SYSTEMIC; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84930674420     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0126707     Document Type: Article

References (81)

1. Kahan A, Allanore Y (2006) Primary myocardial involvement in systemic sclerosis. Rheumatology (Oxford) 45 Suppl 4: iv14-17.
2. Tyndall AJ, Bannert B, Vonk M, Airo P, Cozzi F, Carreira PE, et al. (2010) Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis 69: 1809-1815. doi: 10.1136/ard.2009.114264 PMID: 20551155
3. Czirjak L, Kumanovics G, Varju C, Nagy Z, Pakozdi A, Szekanecz Z, et al. (2008) Survival and causes of death in 366 Hungarian patients with systemic sclerosis. Ann Rheum Dis 67: 59-63. PMID: 17519276
4. Ioannidis JP, Vlachoyiannopoulos PG, Haidich AB, Medsger TA Jr, Lucas M, Michet CJ, et al. (2005) Mortality in systemic sclerosis: an international meta-analysis of individual patient data. Am J Med 118: 2-10. PMID: 15639201
5. Steen VD, Medsger TA (2007) Changes in causes of death in systemic sclerosis, 1972-2002. Ann Rheum Dis 66: 940-944. PMID: 17329309
6. Medsger TA Jr, Masi AT (1973) Survival with scleroderma. II. A life-table analysis of clinical and demographic factors in 358 male U.S. veteran patients. J Chronic Dis 26: 647-660. PMID: 4587746
7. Ferri C, Valentini G, Cozzi F, Sebastiani M, Michelassi C, La Montagna G, et al. (2002) Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients. Medicine (Baltimore) 81: 139-153. PMID: 11889413
8. Steen VD, Medsger TA Jr (2000) Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum 43: 2437-2444. PMID: 11083266
9. Bernardo P, Conforti ML, Bellando-Randone S, Pieragnoli P, Blagojevic J, Kaloudi O, et al. (2011) Implantable cardioverter defibrillator prevents sudden cardiac death in systemic sclerosis. J Rheumatol 38: 1617-1621. doi: 10.3899/jrheum.100480 PMID: 21632680
10. Perera A, Fertig N, Lucas M, Rodriguez-Reyna TS, Hu P, Steen VD, et al. (2007) Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti-topoisomerase I antibody. Arthritis Rheum 56: 2740-2746. PMID: 17665460
11. Henes JC, Schmalzing M, Vogel W, Riemekasten G, Fend F, Kanz L, et al. (2012) Optimization of autologous stem cell transplantation for systemic sclerosis - a single-center longterm experience in 26 patients with severe organ manifestations. J Rheumatol 39: 269-275. doi: 10.3899/jrheum.110868 PMID: 22247352
12. Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, et al. (2006) Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 113: 1807-1816. PMID: 16567565
13. Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, et al. (2008) Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 29: 270-276. PMID: 17916581
14. van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. (2013) 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum 65: 2737-2747. doi: 10.1002/art.38098 PMID: 24122180
15. Diez J (2007) Mechanisms of cardiac fibrosis in hypertension. J Clin Hypertens (Greenwich) 9: 546-550. PMID: 17617765
16. Liangos O, Neure L, Kuhl U, Pauschinger M, Sieper J, Distler A, et al. (2000) The possible role of myocardial biopsy in systemic sclerosis. Rheumatology (Oxford) 39: 674-679. PMID: 10888714
17. Bashandy HG, Javillo JS, Gambert SR (2006) A case of early onset normotensive scleroderma renal crisis in a patient with diffuse cutaneous systemic sclerosis. South Med J 99: 870-872. PMID: 16929883
18. Haviv YS, Safadi R (1998) Normotensive scleroderma renal crisis: case report and review of the literature. Ren Fail 20: 733-736. PMID: 9768442
19. Kohno K, Katayama T, Majima K, Fujisawa M, Iida S, Fukami K, et al. (2000) A case of normotensive scleroderma renal crisis after high-dose methylprednisolone treatment. Clin Nephrol 53: 479-482. PMID: 10879669
20. Helfrich DJ, Banner B, Steen VD, Medsger TA Jr (1989) Normotensive renal failure in systemic sclerosis. Arthritis Rheum 32: 1128-1134. PMID: 2775321
21. Steen VD, Medsger TA Jr (2000) Long-term outcomes of scleroderma renal crisis. Ann Intern Med 133: 600-603. PMID: 11033587
22. Penn H, Howie AJ, Kingdon EJ, Bunn CC, Stratton RJ, Black CM, et al. (2007) Scleroderma renal crisis: patient characteristics and long-term outcomes. QJM 100: 485-494. PMID: 17601770
23. Goh NS, Desai SR, Veeraraghavan S, Hansell DM, Copley SJ, Maher TM, et al. (2008) Interstitial lung disease in systemic sclerosis: a simple staging system. Am J Respir Crit Care Med 177: 1248-1254. doi: 10.1164/rccm.200706-877OC PMID: 18369202
24. Wielosz E, Borys O, Zychowska I, Majdan M (2010) Gastrointestinal involvement in patients with systemic sclerosis. Pol Arch Med Wewn 120: 132-136. PMID: 20424538
25. Schanz S, Henes J, Ulmer A, Kotter I, Fierlbeck G, Claussen CD, et al. (2013) Magnetic resonance imaging findings in patients with systemic scleroderma and musculoskeletal symptoms. Eur Radiol 23: 212-221. doi: 10.1007/s00330-012-2584-1 PMID: 22843057
26. Jiang L, Levine RA, Weyman AE (1997) Echocardiographic Assessment of Right Ventricular Volume and Function. Echocardiography 14: 189-206. PMID: 11174944
27. Tamborini G, Muratori M, Brusoni D, Celeste F, Maffessanti F, Caiani EG, et al. (2009) Is right ventricular systolic function reduced after cardiac surgery? A two- and three-dimensional echocardiographic study. Eur J Echocardiogr 10: 630-634. doi: 10.1093/ejechocard/jep015 PMID: 19252190
28. Fisher MR, Forfia PR, Chamera E, Housten-Harris T, Champion HC, Girgis RE, et al. (2009) Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension. Am J Respir Crit Care Med 179: 615-621. doi: 10.1164/rccm.200811-1691OC PMID: 19164700
29. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, et al. (2008) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 29: 2388-2442. doi: 10.1093/eurheartj/ehn309 PMID: 18799522
30. Mahrholdt H, Wagner A, Deluigi CC, Kispert E, Hager S, Meinhardt G, et al. (2006) Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation 114: 1581-1590. PMID: 17015795
31. Leone O, Veinot JP, Angelini A, Baandrup UT, Basso C, Berry G, et al. (2012) 2011 consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology. Cardiovasc Pathol 21: 245-274. doi: 10.1016/j.carpath.2011.10.001 PMID: 22137237
32. Basso C, Calabrese F, Angelini A, Carturan E, Thiene G (2013) Classification and histological, immunohistochemical, and molecular diagnosis of inflammatory myocardial disease. Heart Fail Rev 18: 673-681. doi: 10.1007/s10741-012-9355-6 PMID: 23096264
33. Mahrholdt H, Goedecke C, Wagner A, Meinhardt G, Athanasiadis A, Vogelsberg H, et al. (2004) Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation 109: 1250-1258. PMID: 14993139
34. Szalay G, Sauter M, Hald J, Weinzierl A, Kandolf R, Klingel K, et al. (2006) Sustained nitric oxide synthesis contributes to immunopathology in ongoing myocarditis attributable to interleukin-10 disorders. Am J Pathol 169: 2085-2093. PMID: 17148671
35. Kindermann I, Kindermann M, Kandolf R, Klingel K, Bultmann B, Muller T, et al. (2008) Predictors of outcome in patients with suspected myocarditis. Circulation 118: 639-648. doi: 10.1161/CIRCULATIONAHA.108.769489 PMID: 18645053
36. Szalay G, Sauter M, Haberland M, Zuegel U, Steinmeyer A, Kandolf R, et al. (2009) Osteopontin: a fibrosis-related marker molecule in cardiac remodeling of enterovirus myocarditis in the susceptible host. Circ Res 104: 851-859. doi: 10.1161/CIRCRESAHA.109.193805 PMID: 19246678
37. Lang C, Sauter M, Szalay G, Racchi G, Grassi G, Rainaldi G, et al. (2008) Connective tissue growth factor: a crucial cytokine-mediating cardiac fibrosis in ongoing enterovirus myocarditis. J Mol Med (Berl) 86: 49-60. PMID: 17846733
38. Pauschinger M, Noutsias M, Lassner D, Schultheiss HP, Kuehl U (2006) Inflammation, ECG changes and pericardial effusion: whom to biopsy in suspected myocarditis? Clin Res Cardiol 95: 569-583. PMID: 16897143
39. Cooper LT, Baughman KL, Feldman AM, Frustaci A, Jessup M, Kuhl U, et al. (2007) The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Circulation 116: 2216-2233. PMID: 17959655
40. Grogan M, Redfield MM, Bailey KR, Reeder GS, Gersh BJ, Edwards WD, et al. (1995) Long-term outcome of patients with biopsy-proved myocarditis: comparison with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 26: 80-84. PMID: 7797779
41. Klingel K, Stephan S, Sauter M, Zell R, McManus BM, Bultmann B, et al. (1996) Pathogenesis of murine enterovirus myocarditis: virus dissemination and immune cell targets. J Virol 70: 8888-8895. PMID: 8971018
42. Hachulla AL, Launay D, Gaxotte V, de Groote P, Lamblin N, Devos P, et al. (2009) Cardiac magnetic resonance imaging in systemic sclerosis: a cross-sectional observational study of 52 patients. Ann Rheum Dis 68: 1878-1884. doi: 10.1136/ard.2008.095836 PMID: 19054830
43. Kobayashi H, Yokoe I, Hirano M, Nakamura T, Nakajima Y, Fontaine KR, et al. (2009) Cardiac magnetic resonance imaging with pharmacological stress perfusion and delayed enhancement in asymptomatic patients with systemic sclerosis. J Rheumatol 36: 106-112. doi: 10.3899/jrheum.080377 PMID: 19040307
44. Tzelepis GE, Kelekis NL, Plastiras SC, Mitseas P, Economopoulos N, Kampolis C, et al. (2007) Pattern and distribution of myocardial fibrosis in systemic sclerosis - A delayed enhanced magnetic resonance imaging study. Arthritis and Rheumatism 56: 3827-3836. PMID: 17968945
45. Pickering JG, Boughner DR (1990) Fibrosis in the transplanted heart and its relation to donor ischemic time. Assessment with polarized light microscopy and digital image analysis. Circulation 81: 949-958. PMID: 2306841
46. Murata I, Takenaka K, Shinohara S, Suzuki T, Sasaki T, Yamamoto K, et al. (1998) Diversity of myocardial involvement in systemic sclerosis: an 8-year study of 95 Japanese patients. Am Heart J 135: 960-969. PMID: 9630099
47. D'Angelo WA, Fries JF, Masi AT, Shulman LE (1969) Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls. Am J Med 46: 428-440. PMID: 5780367
48. Follansbee WP, Miller TR, Curtiss EI, Orie JE, Bernstein RL, Kiernan JM, et al. (1990) A controlled clinicopathologic study of myocardial fibrosis in systemic sclerosis (scleroderma). J Rheumatol 17: 656-662. PMID: 2359076
49. Bulkley BH, Ridolfi RL, Salyer WR, Hutchins GM (1976) Myocardial lesions of progressive systemic sclerosis. A cause of cardiac dysfunction. Circulation 53: 483-490. PMID: 1248080
50. Beranek JT (2001) Pathogenesis of heart fibrosis in systemic sclerosis. Int J Cardiol 80: 261-262. PMID: 11676389
51. Altorok N, Almeshal N, Wang Y, Kahaleh B (2014) Epigenetics, the holy grail in the pathogenesis of systemic sclerosis. Rheumatology (Oxford).
52. Fernandes F, Ramires FJ, Arteaga E, Ianni BM, Bonfa ES, Mady C, et al. (2003) Cardiac remodeling in patients with systemic sclerosis with no signs or symptoms of heart failure: an endomyocardial biopsy study. J Card Fail 9: 311-317. PMID: 13680552
53. Carette S, Turcotte J, Mathon G (1985) Severe myositis and myocarditis in progressive systemic sclerosis. J Rheumatol 12: 997-999. PMID: 4087278
54. Clemson BS, Miller WR, Luck JC, Feriss JA (1992) Acute myocarditis in fulminant systemic sclerosis. Chest 101: 872-874. PMID: 1541169
55. Kerr LD, Spiera H (1993) Myocarditis as a complication in scleroderma patients with myositis. Clin Cardiol 16: 895-899. PMID: 8168276
56. Pieroni M, De Santis M, Zizzo G, Bosello S, Smaldone C, Campioni M, et al. (2014) Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: potential utility of immunosuppressive therapy in cardiac damage progression. Semin Arthritis Rheum 43: 526-535. doi: 10.1016/j.semarthrit.2013.07.006 PMID: 23932313
57. Bock CT, Klingel K, Kandolf R (2010) Human parvovirus B19-associated myocarditis. N Engl J Med 362: 1248-1249. doi: 10.1056/NEJMc0911362 PMID: 20357294
58. Elhai M, Avouac J, Walker UA, Matucci-Cerinic M, Riemekasten G, Airo P, et al. (2014) A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective study. Ann Rheum Dis.
59. Salazar GA, Assassi S, Wigley F, Hummers L, Varga J, Hinchcliff M, et al. (2014) Antinuclear antibody-negative systemic sclerosis. Semin Arthritis Rheum.
60. Seizer P, Geisler T, Bigalke B, Schneider M, Klingel K, Kandolf R, et al. (2011) EMMPRIN and its ligand Cyclophilin A as novel diagnostic markers in inflammatory cardiomyopathy. Int J Cardiol.
61. Zuern CS, Muller KA, Seizer P, Geisler T, Banya W, Klingel K, et al. (2012) Cyclophilin A predicts clinical outcome in patients with congestive heart failure undergoing endomyocardial biopsy. Eur J Heart Fail.
62. Burt RK, Shah SJ, Dill K, Grant T, Gheorghiade M, Schroeder J, et al. (2011) Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial. Lancet 378: 498-506. doi: 10.1016/S0140-6736(11)60982-3 PMID: 21777972
63. Farge D, Labopin M, Tyndall A, Fassas A, Mancardi GL, Van Laar J, et al. (2010) Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years' experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases. Haematologica 95: 284-292. doi: 10.3324/haematol.2009.013458 PMID: 19773265
64. Elhai M, Meune C, Avouac J, Kahan A, Allanore Y (2012) Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies. Rheumatology (Oxford) 51: 1017-1026. doi: 10.1093/rheumatology/ker269 PMID: 21900368
65. Burt RK, Oliveira MC, Shah SJ, Moraes DA, Simoes B, Gheorghiade M, et al. (2013) Cardiac involvement and treatment-related mortality after non-myeloablative haemopoietic stem-cell transplantation with unselected autologous peripheral blood for patients with systemic sclerosis: a retrospective analysis. Lancet 381: 1116-1124. doi: 10.1016/S0140-6736(12)62114-X PMID: 23363664
66. Naraghi K, van Laar JM (2013) Update on stem cell transplantation for systemic sclerosis: recent trial results. Curr Rheumatol Rep 15: 326. doi: 10.1007/s11926-013-0326-2 PMID: 23516015
67. van Laar JM, Farge D, Sont JK, Naraghi K, Marjanovic Z, Larghero J, et al. (2014) Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial. JAMA 311: 2490-2498. doi: 10.1001/jama.2014.6368 PMID: 25058083
68. van Laar JM, Farge D, Tyndall A (2005) Autologous Stem cell Transplantation International Scleroderma (ASTIS) trial: hope on the horizon for patients with severe systemic sclerosis. Ann Rheum Dis 64: 1515. PMID: 16162905
69. Ayash LJ, Wright JE, Tretyakov O, Gonin R, Elias A, Wheeler C, et al. (1992) Cyclophosphamide pharmacokinetics: correlation with cardiac toxicity and tumor response. J Clin Oncol 10: 995-1000. PMID: 1588381
70. Zver S, Zadnik V, Bunc M, Rogel P, Cernelc P, Kozelj M, et al. (2007) Cardiac toxicity of high-dose cyclophosphamide in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplantation. Int J Hematol 85: 408-414. PMID: 17562616
71. Saccardi R, Tyndall A, Coghlan G, Denton C, Edan G, Emdin M, et al. (2004) Consensus statement concerning cardiotoxicity occurring during haematopoietic stem cell transplantation in the treatment of autoimmune diseases, with special reference to systemic sclerosis and multiple sclerosis. Bone Marrow Transplant 34: 877-881. PMID: 15517007
72. Chen TL, Passos-Coelho JL, Noe DA, Kennedy MJ, Black KC, Colvin OM, et al. (1995) Nonlinear pharmacokinetics of cyclophosphamide in patients with metastatic breast cancer receiving high-dose chemotherapy followed by autologous bone marrow transplantation. Cancer Res 55: 810-816. PMID: 7850794
73. Henes JC, Koetter I, Horger M, Schmalzing M, Mueller K, Eick C, et al. (2014) Autologous stem cell transplantation with thiotepa-based conditioning in patients with systemic sclerosis and cardiac manifestations. Rheumatology (Oxford) 53: 919-922. doi: 10.1093/rheumatology/ket464 PMID: 24459219
74. Rosen O, Massenkeil G, Hiepe F, Pest S, Hauptmann S, Radtke H, et al. (2001) Cardiac death after autologous stem cell transplantation (ASCT) for treatment of systemic sclerosis (SSc): no evidence for cyclophosphamide-induced cardiomyopathy. Bone Marrow Transplant 27: 657-658. PMID: 11319598
75. Coghlan JG, Mukerjee D (2001) The heart and pulmonary vasculature in scleroderma: clinical features and pathobiology. Curr Opin Rheumatol 13: 495-499. PMID: 11698727
76. Murdych T, Weisdorf DJ (2001) Serious cardiac complications during bone marrow transplantation at the University of Minnesota, 1977-1997. Bone Marrow Transplant 28: 283-287. PMID: 11535997
77. Gottdiener JS, Appelbaum FR, Ferrans VJ, Deisseroth A, Ziegler J (1981) Cardiotoxicity associated with high-dose cyclophosphamide therapy. Arch Intern Med 141: 758-763. PMID: 7235784
78. Goldberg MA, Antin JH, Guinan EC, Rappeport JM (1986) Cyclophosphamide cardiotoxicity: an analysis of dosing as a risk factor. Blood 68: 1114-1118. PMID: 3533179
79. Appelbaum F, Strauchen JA, Graw RG Jr, Savage DD, Kent KM, Ferrans VJ, et al. (1976) Acute lethal carditis caused by high-dose combination chemotherapy. A unique clinical and pathological entity. Lancet 1: 58-62. PMID: 54581
80. Burt RK, Shah SJ, Gheorghiade M, Ruderman E, Schroeder J (2012) Hematopoietic stem cell transplantation for systemic sclerosis: if you are confused, remember: "it is a matter of the heart". J Rheumatol 39: 206-209. doi: 10.3899/jrheum.111302 PMID: 22298260
81. Nash RA, McSweeney PA, Crofford LJ, Abidi M, Chen CS, Godwin JD, et al. (2007) High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study. Blood 110: 1388-1396. PMID: 17452515